文献速递脊柱外科

非甾体抗炎药与阿片类药物对脊柱融合的抑制作用:动物模型研究

The Inhibitory Effect of NSAIDs and Opioids on Spinal Fusion: An Animal Model.
PubMed 文献 · Spine (Phila Pa 1976) · 2024-02-13

研究在大鼠后路腰椎融合模型中比较盐水、吗啡、酮咯酸及两药联用对融合的影响。结果显示各用药组手法触诊评分、microCT融合评分与融合率均显著低于对照组,阿片组融合率最低(0%),作者提出可能与抑制VEGF-A、限制血管新生有关。

要点

  • 各用药组手法触诊评分、microCT融合评分及融合率均显著低于对照组(P<0.001)。
  • 融合率对照组75%、非甾体抗炎药组35%、阿片组0%、联合组15%(P<0.001)。
  • 阿片组与非甾体抗炎药联合组骨密度最低,VEGF-A组间差异未达统计学显著(P<0.09)。

核心结论

  • 阿片类药物与非甾体抗炎药单独或联合使用均抑制脊柱融合并导致骨痂质量较差。
  • 给予阿片类药物导致最低的脊柱融合率。
  • 作者提出这可能与抑制VEGF-A、限制新生融合块的血管生成有关。

研究设计与样本

  • 转化研究,80只雄性Sprague-Dawley大鼠行L4-5后路腰椎融合。
  • 大鼠随机接受以下镇痛方案之一:盐水、吗啡(6 mg/kg)、酮咯酸(4 mg/kg)或吗啡(3 mg/kg)联合酮咯酸(2 mg/kg)。
  • 通过酶联免疫吸附试验(ELISA)检测血清促成骨细胞因子和血管内皮生长因子-A(VEGF-A)水平。
  • 六周后处死大鼠,对手术脊柱节段行手法触诊、microCT和组织学分析。

主要发现

  • 手法触诊评分在阿片组、非甾体抗炎药组和联合组均显著低于对照组(P<0.001)。
  • microCT融合评分(P<0.001)和融合率(对照组75% vs 非甾体抗炎药组35% vs 阿片组0% vs 联合组15%,P<0.001)在各治疗组均显著降低。
  • 骨体积与组织体积比值(BV/TV)(P<0.001)和骨密度(BMD)(P<0.001)在各治疗组均较低,其中阿片组和联合组骨密度最低。
  • VEGF-A浓度对照组高于阿片组、非甾体抗炎药组和联合组,但差异未达统计学显著(P<0.09)。

关键数值与推荐

  • 融合率:对照组75%、非甾体抗炎药组35%、阿片组0%、联合组15%(P<0.001)。
  • 手法触诊评分、microCT融合评分、BV/TV比值和BMD在各治疗组均显著低于对照组(P<0.001)。
  • VEGF-A浓度对照组高于各治疗组,但差异未达统计学显著(P<0.09)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Translational research. OBJECTIVE: To evaluate the relative effects of NSAIDs, opioids, and a combination of the two on spinal fusion inhibition in a rodent model. SUMMARY OF BACKGROUND DATA: Nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids are common postoperative analgesic agents. Since NSAIDs inhibit the cyclooxygenase (COX) pathway, they are seldom prescribed following spinal fusion. Opioids may be given instead, but recent evidence suggests opioids also adversely affect spinal fusion quality and success. METHODS: Eighty male Sprague-Dawley rats underwent L4-5 posterior lumbar fusion and were given one of the following analgesia regimens: saline, morphine (6 mg/kg), ketorolac (4 mg/kg), or morphine (3 mg/kg) and ketorolac (2 mg/kg). Serum samples were drawn to evaluate systemic pro-osteoblastic cytokines and vascular endothelial growth factor-A (VEGF-A) levels, which were measured through enzyme-linked immunosorbent assays (ELISA). After six weeks, the rats were sacrificed, and the operated spinal segments underwent manual palpation, microCT, and histologic analysis. RESULTS: Manual palpation scores were significantly diminished in the opioid, NSAID, and multimodal groups when compared with control ( P <0.001). MicroCT fusion scores ( P <0.001) and fusion rates (control: 75% vs . NSAID: 35% vs . opioid: 0% vs . combination: 15%, P <0.001) were significantly diminished in the treatment groups. The bone volume (BV) to tissue volume (TV) ratio (BV/TV) ( P <0.001) and bone mineral density (BMD) ( P <0.001) were all lower in the treatment groups, with the opioid and combined groups having the lowest BMD. Although statistically insignificant ( P <0.09), the concentration of VEGF-A was greater in the control group compared with opioids, NSAIDs, and the combined group. CONCLUSION: Opioids and NSAIDs, both independently and combined, inhibited spinal fusion and caused inferior bony callus. Administration of opioids resulted in the lowest rate of spinal fusion. We propose this may be due to the inhibition of VEGF-A, which limits angiogenesis to the burgeoning fusion mass.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Lambrechts MJ, D'Antonio ND, Heard JC, et al. The Inhibitory Effect of NSAIDs and Opioids on Spinal Fusion: An Animal Model. Spine (Phila Pa 1976). 2024. PMID: 38348858. doi:10.1097/BRS.0000000000004959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。